0001562180-20-003210.txt : 20200429 0001562180-20-003210.hdr.sgml : 20200429 20200429202048 ACCESSION NUMBER: 0001562180-20-003210 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200427 FILED AS OF DATE: 20200429 DATE AS OF CHANGE: 20200429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLDSMITH MARK A CENTRAL INDEX KEY: 0001246842 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38584 FILM NUMBER: 20832699 MAIL ADDRESS: STREET 1: 925 PAGE MILL ROAD CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CONSTELLATION PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001434418 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-714-0555 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 200 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2020-04-27 false 0001434418 CONSTELLATION PHARMACEUTICALS INC CNST 0001246842 GOLDSMITH MARK A C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142 true false true false Common Stock 2020-04-27 4 M false 400.00 1.55 A 143463.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Common Stock 2020-04-27 4 S false 400.00 40.1225 D 143063.00 I Owned by Trusts for which Mark A. Goldsmith is a Trustee Stock Option (Right to Buy) 1.55 2020-04-27 4 M false 400.00 0.00 D 2021-03-10 Common Stock 400.00 26850.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. This transaction was executed in multiple trades at prices ranging from $40.03 to $40.16. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares are fully vested. /s/ Emma Reeve, as Attorney-in-Fact for Mark A. Goldsmith 2020-04-29